Ashkon Software



CBRX - Columbia Laboratories, Inc.

CBRX Stock Chart

CBRX Profile

Columbia Laboratories, Inc. logo

Columbia Laboratories, Inc. (CBRX) is a publicly-traded biopharmaceutical company that develops women's health and reproductive medicine products. The company was founded in 1986 and is headquartered in Boston, Massachusetts.

Columbia Laboratories' primary focus is on developing products that address unmet needs in women's reproductive health, including products for infertility, menstrual disorders, and preterm birth. The company's products are designed to improve the chances of successful pregnancies and reduce the risk of premature birth.

One of the company's most significant products is PROCHIEVE, which is a vaginal gel that contains progesterone, a hormone that is essential for maintaining a healthy pregnancy. PROCHIEVE is used to support women who have had recurrent pregnancy loss and women undergoing in vitro fertilization (IVF) treatment.

In addition to its reproductive medicine products, Columbia Laboratories also develops products that improve drug delivery, including the CRINONE progesterone gel, which uses the company's proprietary bioadhesive technology to deliver progesterone in a consistent and efficient manner.

Columbia Laboratories has a diverse portfolio of products and has partnerships with several pharmaceutical companies, including Watson Pharmaceuticals and Merck Serono. The company also collaborates with academic institutions and research organizations to develop new products and technologies.

As of September 2021, the company's stock was traded on the OTC Pink market under the symbol &";


Copyright © 2000-2024, Ashkon Software LLC
Privacy Policy | Refund Policy | Disclaimer